Skip to main content

Table 2 Virtual trial results summary for STAR-2D and STAR-3D

From: 3D kernel-density stochastic model for more personalized glycaemic control: development and in-silico validation

  STAR-2D STAR-3D
Number of patients 681 681
Hours of control (h) 59,073 59,071
Total BG measurements 31,248 31,858
Workload (measurements per day) 12.7 12.9
Median [IQR] BG (mmol/L) 6.3 [5.7 7.0] 6.2 [5.6 6.9]
% BG in 4.4–6.5 mmol/L 56 61
% BG in 4.4–7.0 mmol/L 72 75
% BG in 4.4–8.0 mmol/L 88 88
% BG in 8.0–10.0 mmol/L 8 7
% BG > 10.0 mmol/L 3 3
% BG < 4.4 mmol/L 2 2
% BG < 4.0 mmol/L 1 1
% BG < 2.2 mmol/L 0.03 0.03
# patients < 2.2 mmol/L 11 (1.6%) 11 (1.6%)
Median [IQR] insulin rate (U/h) 2.5 [1.5 4.5] 3.0 [1.5 5.0]
Median [IQR] dextrose rate (%GF) 95 [40 100] 97 [36 100]